Literature DB >> 6478112

Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptors.

P R Saxena, P D Verdouw.   

Abstract

The effects of acute (50-350 micrograms kg-1, i.v.) and subacute (350 micrograms kg-1 orally per day for six days) administration of methysergide, and of intra-arterial infusions of 0.5 and 2.0 micrograms kg-1 min-1 5-hydroxytryptamine (5-HT) on the distribution of carotid blood flow into the capillary (nutrient) and arterio-venous anastomotic (AVA) fractions were studied in anaesthetized pigs. The acute, but not the subacute, administration of methysergide caused a moderate reduction of carotid blood flow. This reduction, noticed only in the AVA fraction, was due to a constriction of the arterio-venous anastomoses (AVAs). Both doses of 5-HT reduced total carotid blood flow but its nutrient fraction--particularly that distributed to the skin and ears--increased substantially. The AVA fraction was greatly diminished. After treatment with methysergide, 5-HT no longer reduced the total carotid blood flow, but increased it. Despite this reversal the constriction of AVAs by the amine was only slightly diminished. On the other hand, the vasodilatation of the nutrient channels was enhanced. The results of the interaction between methysergide and 5-HT provide further evidence for the presence of 'atypical' 5-HT receptors (probably corresponding to 5-HT1 binding sites) mediating AVA contraction and nutrient vasodilatation. The 5-HT2 receptors mediate vasoconstriction and are located in the large conducting arteries and possibly, in smaller numbers, in the AVAs and arterioles.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478112      PMCID: PMC1986919          DOI: 10.1111/j.1476-5381.1984.tb16478.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  ARTERIOVENOUS SHUNTS IN THE BLOOD SUPPLY TO THE BRAINS OF SOME COMMON LABORATORY ANIMALS--WITH SPECIAL ATTENTION TO THE RETE MIRABILE CONJUGATUM IN THE CAT.

Authors:  L A GILLILAN; W R MARKESBERY
Journal:  J Comp Neurol       Date:  1963-12       Impact factor: 3.215

2.  Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.

Authors:  F SICUTERI
Journal:  Int Arch Allergy Appl Immunol       Date:  1959

3.  Arteriovenous anastomoses in the external ear.

Authors:  P M DANIEL; M M PRICHARD
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1956-04

4.  Relation of structure to function of the tissues of the wall of blood vessels.

Authors:  A C BURTON
Journal:  Physiol Rev       Date:  1954-10       Impact factor: 37.312

5.  Hypotensive activity of serotonin receptor agonists in rats is related to their affinity for 5-HT1 receptors.

Authors:  H O Kalkman; H W Boddeke; H N Doods; P B Timmermans; P A Van Zwieten
Journal:  Eur J Pharmacol       Date:  1983-07-15       Impact factor: 4.432

6.  Modification of the vasomotor actions of methysergide in the femoral arterial bed of the anaesthetized dog by changes in sympathetic nerve activity.

Authors:  W Feniuk; P P Humphrey; A D Watts
Journal:  J Auton Pharmacol       Date:  1981-03

7.  Vascular effects of ergot alkaloids: a study on human basilar arteries.

Authors:  E Müller-Schweinitzer
Journal:  Gen Pharmacol       Date:  1983

8.  Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves.

Authors:  G Engel; M Göthert; E Müller-Schweinitzer; E Schlicker; L Sistonen; P A Stadler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

9.  Capillary diameter and geometry in cardiac and skeletal muscle studied by means of corrosion casts.

Authors:  R F Potter; A C Groom
Journal:  Microvasc Res       Date:  1983-01       Impact factor: 3.514

10.  Two kinds of tryptamine receptor.

Authors:  J H GADDUM; Z P PICARELLI
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  15 in total

1.  Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.

Authors:  S J MacLennan; G R Martin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

Review 2.  Pharmacology of antimigraine drugs.

Authors:  P R Saxena; M O Den Boer
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

3.  Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.

Authors:  M O den Boer; J P Heiligers; P R Saxena
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

4.  Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors.

Authors:  P R Saxena; E J Mylecharane; J Heiligers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

5.  Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.

Authors:  C M Villalón; P De Vries; G Rabelo; D Centurión; A Sánchez-López; P Saxena
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of "5-hydroxytryptamine1-like" receptors.

Authors:  P R Saxena; D J Duncker; A H Bom; J Heiligers; P D Verdouw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

7.  Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan.

Authors:  M O den Boer; C M Villalón; J P Heiligers; P P Humphrey; P R Saxena
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

8.  5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses.

Authors:  P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

9.  5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor.

Authors:  A H Bom; D J Duncker; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

10.  5-HT1-like receptor mediated changes in porcine carotid haemodynamics: are 5-HT1D receptors involved?

Authors:  M O Den Boer; C M Villalón; P R Saxena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.